Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Non-Current Debt (2021 - 2024)

Roivant Sciences' Non-Current Debt history spans 4 years, with the latest figure at $37.8 million for Q2 2024.

  • For Q2 2024, Non-Current Debt rose 6.67% year-over-year to $37.8 million; the TTM value through Jun 2024 reached $37.8 million, up 6.67%, while the annual FY2024 figure was $188.7 million, 17.97% up from the prior year.
  • Non-Current Debt reached $37.8 million in Q2 2024 per ROIV's latest filing, down from $188.7 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $204.0 million in Q4 2021 to a low of $32.6 million in Q1 2022.
  • Average Non-Current Debt over 4 years is $123.9 million, with a median of $160.0 million recorded in 2023.
  • Peak YoY movement for Non-Current Debt: crashed 83.22% in 2022, then skyrocketed 402.21% in 2023.
  • A 4-year view of Non-Current Debt shows it stood at $204.0 million in 2021, then tumbled by 83.22% to $34.2 million in 2022, then surged by 402.21% to $172.0 million in 2023, then crashed by 78.02% to $37.8 million in 2024.
  • Per Business Quant, the three most recent readings for ROIV's Non-Current Debt are $37.8 million (Q2 2024), $188.7 million (Q1 2024), and $172.0 million (Q4 2023).